GlassScriptPhysician profile
Jaclyn Thuman
NPI 1053916528
$1,231.61
in general payments reported to CMS, 2019-2025
15 companies · $61.88 in 2025
The $61.88 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $604 · 2022: $381 · 2023: $18.52 · 2024: $166 · 2025: $61.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $246.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $419.89 | 2021-2022 | |
| Vertos Medical, INC. | $157.06 | 2023-2024 | Mild Device Kit |
| Nestle Healthcare Nutrition INC. | $113.56 | 2021-2022 | |
| Intercept Pharmaceuticals, INC. | $89.41 | 2021-2022 | |
| Vivus LLC | $81.32 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $64.60 | 2021-2022 | |
| Gilead Sciences, INC. | $56.42 | 2021 | |
| Boston Scientific Corporation | $50.78 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Spinal Simplicity, LLC | $38.65 | 2025 | Ha Minuteman G3-R |
| Alnylam Pharmaceuticals INC. | $36.84 | 2021 | |
| Janssen Biotech, INC. | $36.28 | 2021-2022 | |
| Ironwood Pharmaceuticals, INC | $24.62 | 2021 | |
| Daiichi Sankyo INC. | $24.13 | 2021 | |
| Redhill Biopharma INC. | $19.14 | 2021 | |
| Qol Medical, LLC | $18.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaclyn Thuman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.